| Filed On | Filing |
|---|---|
| 05 Mar 2025 |
8-K/A: Entry into a Material Definitive Agreement; Regulation FD Disclosure
Form of Certificate of Incorporation of the Surviving Corporation |
| 19 Jul 2021 |
8-K/A: Financial Statements and Exhibits
To the stockholders and the Board of Directors of GW Pharmaceuticals plc |
| 27 Sep 2016 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated balance sheets of Celator Pharmaceuticals, Inc. and subsidiaries (the Company) as of December 31, 2015 and 2014, and the related consolidated statements of loss, stockholders’ equity, and cas... |
| 01 Jun 2016 |
8-K/A: Regulation FD Disclosure
Acquisition of Celator Pharmaceuticals May 31, 2016 Exhibit 99.2 |
| 01 Apr 2014 |
8-K/A: Financial Statements and Exhibits
Consolidated Balance Sheets as of December 31, 2012 and 2013 |
| 20 Dec 2013 |
8-K/A: Entry into a Material Definitive Agreement
This TENDER OFFER AGREEMENT (this “Agreement”) is made and entered into as of December 19, 2013 (the “Agreement Date”) by and among Jazz Pharmaceuticals Public Limited Company, a public limited company formed under the laws of Ireland (“... |
| 10 Aug 2012 |
8-K/A: Financial Statements and Exhibits
In our opinion, the accompanying consolidated balance sheets and the consolidated statements of operations, changes in redeemable convertible preferred stock and stockholders’ equity and cash flows present fairly, in all material respect... |
| 23 Feb 2009 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
Loading...